Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Demcizumab in First-Line Stage IV Non-Squamous NSCLC
NCT02259582Phase 2Completed
- Sponsor
- OncoMed Pharmaceuticals
- Start
- Feb 2015
- Primary completion
- Apr 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of demcizumab in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by OncoMed Pharmaceuticals. Started Feb 2015; status: completed.
02
Drugs
demcizumab
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT02259582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259582.